3-(2-AMINO-4-PYRIMIDINYL)BENZENECARBONITRILE, 95.0%, 25g

2-(2-Chloro-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

2,4-Difluoro-6-nitrophenol, 95.0%, 1g

Methyl 1,3-Benzoxazole-7-carboxylate, 97.0%, 5g

2,4-dimethyl-1H-1,3-benzodiazole, 97%, 5g

3,4-Dibromo-2-pyridinamine, 250mg

Screw vials conical, 1.5 ml, 500 Piece(s)

2-Benzyl 8-(tert-butyl) 3-(hydroxymethyl)-2,8-diazaspiro[4.5]decane-2,8-dicarboxylate, 97%, 100mg

(2R,4S,5R)-3-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, 98%, 1g

1-(3,5-Bis(trifluoromethyl)phenyl)-3-((1R,2R)-2-(dipentylamino)cyclohexyl)thiourea, 97%, 100mg

(S)-2-Benzyl-aziridine, 97.0%, 5g

6-Bromo-4-iodo-1H-indazole, 95.0%, 250mg

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)